Communication, Multidisciplinary Collaboration, and Future Outlook in Hypoparathyroidism

Dr. Shoback emphasizes the importance of involving family members early, since patients are often trying to manage the disease alone. She highlights community support groups—including the Hypoparathyroidism Association, which holds meetings for patients and caregivers—as a valuable resource for both information and peer support. Dr. Cusano notes that two of her own patients found each other through a support group and have benefited greatly. When significant depression, anxiety, or other mental health complications are present, referral to a mental health provider—whether for medication, counseling, or family therapy—is essential. She underscores that there is no single path for these patients, and that intensive, individualized care with frequent appointments and maximum support is often necessary.

On adherence, Dr. Shoback advocates for engaging patients in actively tracking their own labs and medications, using computers or phones as tools. Positive feedback, clear rescue dosing instructions, and empowering patients to feel "in the driver's seat" of their own management are central strategies. She frames this as applying the same principles used in other chronic disease management—tailored to the individual.

Dr. Lubitz adds that consistent messaging with primary care providers is critical, particularly to prevent misinterpretation of intentionally low-normal calcium values as a laboratory emergency requiring dose escalation.

Dr. Cusano then opens the floor to all panelists on the future of hypoparathyroidism management. Dr. Khosravi anticipates refinement of guidelines as real-world and randomized data mature, better surgical identification techniques such as autofluorescence, potential cell-based therapies, point-of-care calcium monitoring, and precision medicine approaches like encaleret for ADH1. Dr. Ferenczi urges greater referral of patients with genetic forms who remain undiagnosed or undertreated, and emphasizes that emerging therapies can meaningfully improve quality of life for those patients if they reach appropriate specialists.

Thank you for watching this HCPLive Peer Exchange series on hypoparathyroidism. Please subscribe to our enewsletter for information on upcoming video series.